T. Shaw

机构：AbbVie (United States), AbbVie (United Kingdom)

发表论文 29 篇 · 总被引 699 次 · h-index 8

代表论文

• Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial (2010 · Annals of the Rheumatic Diseases · 被引 304)
• Efficacy and safety of various repeat treatment dosing regimens of rituximab in patients with active rheumatoid arthritis: results of a Phase III randomized study (MIRROR) (2010 · Lara D. Veeken · 被引 184)
• Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients (2009 · Annals of the Rheumatic Diseases · 被引 87)
• Transition of Adolescents to Young Adulthood for Vulnerable Populations (2010 · Pediatrics in Review · 被引 22)
• Rituximab (RTX) plus Methotrexate (MTX) prevents bone erosion and joint-space narrowing (JSN) and reduces synovitis, osteitis as shown on MRI: Results from a randomised, placebo-controlled trial in patients (PTS) with rheumatoid arthritis (RA-score) (2011 · Research at the University of Copenhagen (University of Copenhagen) · 被引 18)
• Cohort Profile: Post-Hospitalisation COVID-19 (PHOSP-COVID) study (2023 · International Journal of Epidemiology · 被引 17)